Skip to main content
. 2023 Dec 12;21(12):e8442. doi: 10.2903/j.efsa.2023.8442

TABLE 64.

Reported confirmed human cases of congenital toxoplasmosis and notification rates per 100,000 live births in EU MSs and non‐MS countries by country and year, 2017–2021.

Country 2021 2020 2019 2018 2017
National coverage a Data format a Confirmed cases and rate Confirmed cases and rate Confirmed cases and rate Confirmed cases and rate Confirmed cases and rate
Cases Rate Cases Rate Cases Rate Cases Rate Cases Rate
Austria b
Belgium b
Bulgaria Y A 0 0 0 0 0 0 0 0 2 3.1
Croatia Y C 0 0 0 0 0 0 1 2.7 0 0
Cyprus Y C 0 0 0 0 0 0 0 0 0 0
Czechia Y C 4 3.6 0 0 1 0.88 0 0 2 1.8
Denmark b
Estonia Y C 0 0 0 0 0 0 1 7.2 0 0
Finland Y C 0 0 0 0 0 0 0 0 0 0
France Y C 117 16.9 110 15.5 134 18.8 151 20.8 153 20.7
Germany Y C 11 1.4 14 1.8 17 2.2 18 2.3 8 1.0
Greece c Y C 0 0 0 0 0 0
Hungary Y C 1 1.1 0 0 1 1.1 0 0 0 0
Ireland Y C 0 0 0 0 0 0 0 0 0 0
Italy b
Latvia Y C 0 0 0 0 1 5.2 0 0 0 0
Lithuania Y C 0 0 0 0 0 0 0 0 0 0
Luxembourg Y C 0 0 0 0 0 0 0 0 0 0
Malta Y C 0 0 0 0 0 0 0 0 0 0
Netherlands b
Poland Y C 13 3.7 9 2.5 14 3.7 25 6.3 18 4.8
Portugal Y C 2 2.4
Romania Y C 0 0 0 0 0 0 1 0.48 0 0
Slovakia Y C 0 0 0 0 0 0 0 0 0 0
Slovenia Y C 0 0 0 0 1 5.1 2 9.9 2 9.8
Spain d N C 2 0 0 2 3
Sweden b
EU Total 27 150 5.6 133 5.1 169 6.2 201 7.1 188 6.6
United Kingdom 7 1.0 7 0.91 7 0.91
EU Total e 150 5.6 133 5.1 176 5.1 208 5.8 195 5.4
Iceland Y C 0 0 0 0 0 0 0 0 0 0
Norway b
Liechtenstein b
Switzerland b

Abbreviations: MSs, Member States; –, Data not reported.

a

Y, yes; N, no; A, aggregated data; C, case‐based data.

b

Not notifiable, no surveillance system in place.

c

No data reported in 2021 and 2020.

d

Notification rate was not calculated since information on estimated coverage was not available.

e

Data for the United Kingdom were collected for 2017–2019 since it was still an EU MS. However, on 1 February 2020, it became a third country.